Other grades of this product :
| Siremadlin Basic information |
| Product Name: | Siremadlin | | Synonyms: | (6S)-5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-Pyrrolo[3,4-d]imidazol-4(1H)-one;HDM-201;NVP-HDM201;CS-2613;CS-2787;HDM201; HDM 201; HDM-201; NVP-HDM201; NVP-HDM-201; NVP-HDM 201;(S)-5-(5-chloro-1-methyl-2-oxo-1,2-dihydropyridin-3-yl)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-1-isopropyl-5,6-dihydropyrrolo[3,4-d]imidazol-4(1H)-one;Siremadlin | | CAS: | 1448867-41-1 | | MF: | C26H24Cl2N6O4 | | MW: | 555.41 | | EINECS: | | Product Categories: | | Mol File: | 1448867-41-1.mol |
| Siremadlin Chemical Properties |
| Boiling point | 736.5±70.0 °C(Predicted) | | density | 1.47±0.1 g/cm3(Predicted) | | pka | 1.33±0.29(Predicted) |
| Siremadlin Usage And Synthesis |
| Uses | Siremadlin is an oral biologic agent that is a selective inhibitor of the p53-MDM2 interaction and is being investigated for the treatment of patients with myeloid malignancies after showing single agent activity in preclinical studies. the safety profile of Siremadlin did not differ significantly between tumor types and treatment regimens. |
| Siremadlin Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye